Kaïdre Bendjama

9PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 15, 2026
A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial.

|Jan 09, 2025
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

Emma J West, Alain Sadoun, Kaidre Bendjama

|Apr 19, 2022
Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.

Adel Samson, Emma J West, Jonathan Carmichael

|Apr 01, 2022
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer.

Katy McCann, Adrian von Witzleben, Jaya Thomas

|Jun 07, 2021
BERTMHC: improved MHC-peptide class II interaction prediction with transformer and multiple instance learning.

Jun Cheng, Kaïdre Bendjama, Karola Rittner

|Aug 03, 2019
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial.

Fabien Zoulim, Claire Fournier, François Habersetzer

Pageof 2

Frequent Collaborators

2 joint publications

Christian Ottensmeier

2 joint publications

Adel Samson

2 joint publications

Emma J West

2 joint publications

Fiona J Collinson